Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Dive

Showing results (161-170 of 204) with videos related to

Pageof 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2018
The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung CancerAlice Lallo, Kristopher K Frese, Christopher J Morrow, et al.
BMC Cancer|October 25, 2024
The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitorsMargherita Carucci, Andrew Clamp, Cong Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumorsLeena Gandhi, D Ross Camidge, Moacyr Ribeiro de Oliveira, et al.
BMJ Open|December 26, 2024
Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trialFinbar Slevin, Sophie Alexander, Sarah R Brown, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung CancerAlessia Catozzi, Maria Peiris-Pagès, Sam Humphrey, et al.
Nature Communications|May 21, 2026
Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trialRebecca J Lee, Dominic G Rothwell, Nigel Smith, et al.
Nature Cell Biology|October 2, 2023
Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasisFangfei Qu, Siqi C Brough, Wojciech Michno, et al.
Translational Lung Cancer Research|May 20, 2021
EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancerVictoria Foy, Colin R Lindsay, Alexandra Carmel, et al.
Magnetic Resonance in Medicine|June 27, 2013
Noninvasive tumor hypoxia measurement using magnetic resonance imaging in murine U87 glioma xenografts and in patients with glioblastomaInna V Linnik, Marietta L J Scott, Katherine F Holliday, et al.
Cell Reports|July 5, 2016
Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung CancerNadine S Jahchan, Jing Shan Lim, Becky Bola, et al.
Pageof 21

Showing results (161-170 of 204) with videos related to

Sort By:
Pageof 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2018
The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung CancerAlice Lallo, Kristopher K Frese, Christopher J Morrow, et al.
BMC Cancer|October 25, 2024
The VALTIVE1 study protocol: a study for the validation of Tie2 as the first tumour vascular response biomarker for VEGF inhibitorsMargherita Carucci, Andrew Clamp, Cong Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 2, 2011
Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumorsLeena Gandhi, D Ross Camidge, Moacyr Ribeiro de Oliveira, et al.
BMJ Open|December 26, 2024
Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trialFinbar Slevin, Sophie Alexander, Sarah R Brown, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung CancerAlessia Catozzi, Maria Peiris-Pagès, Sam Humphrey, et al.
Nature Communications|May 21, 2026
Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trialRebecca J Lee, Dominic G Rothwell, Nigel Smith, et al.
Nature Cell Biology|October 2, 2023
Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasisFangfei Qu, Siqi C Brough, Wojciech Michno, et al.
Translational Lung Cancer Research|May 20, 2021
EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancerVictoria Foy, Colin R Lindsay, Alexandra Carmel, et al.
Magnetic Resonance in Medicine|June 27, 2013
Noninvasive tumor hypoxia measurement using magnetic resonance imaging in murine U87 glioma xenografts and in patients with glioblastomaInna V Linnik, Marietta L J Scott, Katherine F Holliday, et al.
Cell Reports|July 5, 2016
Identification and Targeting of Long-Term Tumor-Propagating Cells in Small Cell Lung CancerNadine S Jahchan, Jing Shan Lim, Becky Bola, et al.
Pageof 21